Beth Israel Deaconess Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2017

  1. Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody

    Clinical Cancer Research, Vol. 23, Núm. 8, pp. 1929-1936

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine